People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CERo Therapeutics, Inc. | — | Pharma | Series C | $44.6M | $1.5B | 2017 |
Daniel Mark Corey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Mark Corey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stan Mark Riddell | 1 | 1 |
| Heather Mark Turner | 1 | 1 |
| Stuart Mark Sloan | 1 | 1 |
| Lawrence Corey | 1 | 1 |
| Jordan Corey | 1 | 1 |
| Jordan Thomas Corey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.